Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33811
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLi Wai Suen, Christopher F D-
dc.contributor.authorSeah, Dean-
dc.contributor.authorChoy, Matthew C-
dc.contributor.authorDe Cruz, Peter P-
dc.date2023-
dc.date.accessioned2023-09-27T05:36:41Z-
dc.date.available2023-09-27T05:36:41Z-
dc.date.issued2023-09-19-
dc.identifier.citationInflammatory Bowel Diseases 2023-09-19en_US
dc.identifier.issn1536-4844-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33811-
dc.description.abstractAcute severe ulcerative colitis (ASUC) is a medical emergency for which colectomy is required in patients who do not respond to rescue therapy. While previous studies have predominantly focused on predicting outcome to first-line corticosteroid therapy, there is a need to understand the factors associated with response to rescue therapies in order to improve clinical outcomes. We reviewed the evidence regarding factors associated with response to rescue therapy in adults with ASUC and identified future directions for research. A systematic search of the literature was conducted, and 2 reviewers independently assessed studies for inclusion. Of 3509 records screened, 101 completed studies were eligible for inclusion. We identified 42 clinical, hematological, biochemical, endoscopic, or pharmacological factors associated with response to rescue therapy. Older age (≥50 years), thiopurine experience, and cytomegalovirus or Clostridioides difficile infection were associated with a higher risk of nonresponse to rescue therapy. Biochemical factors associated with poorer response included an elevated C-reactive protein (CRP) ≥30mg/L on admission, hypoalbuminemia and an elevated ratio of CRP to albumin. Severe endoscopic findings, including a Mayo endoscopic score of 3 or Ulcerative Colitis Endoscopic Index of Severity ≥5, portended poorer outcomes. The role of fecal calprotectin and therapeutic value of measuring infliximab drug levels in ASUC remain to be defined. Response to rescue therapy can be predicted by several specific factors, which would aid clinical decision-making. Existing and emerging factors should be integrated within predictive and prognostic models to help improve clinical outcomes.en_US
dc.language.isoeng-
dc.subjectacute severe ulcerative colitisen_US
dc.subjectcolectomyen_US
dc.subjectcyclosporinen_US
dc.subjectinfliximaben_US
dc.subjectprognosisen_US
dc.titleFactors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInflammatory Bowel Diseasesen_US
dc.identifier.affiliationGastroenterology and Hepatologyen_US
dc.identifier.affiliationDepartment of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.doi10.1093/ibd/izad183en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-4095-1153en_US
dc.identifier.orcid0000-0003-3317-1888en_US
dc.identifier.orcid0000-0001-5206-0097en_US
dc.identifier.orcid0000-0002-3399-7236en_US
dc.identifier.pubmedid37725044-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Nov 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.